SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-19-077299
Filing Date
2019-12-31
Accepted
2019-12-31 16:02:46
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tv535518-s3.htm S-3 221961
2 EXHIBIT 4.1 tv535518_ex4-1.htm EX-4.1 10624
3 EXHIBIT 5.1 tv535518_ex5-1.htm EX-5.1 15337
4 EXHIBIT 23.1 tv535518_ex23-1.htm EX-23.1 2445
5 GRAPHIC tv535518_ex4-1img001.jpg GRAPHIC 288227
6 GRAPHIC tv535518_ex4-1img002.jpg GRAPHIC 335966
7 GRAPHIC tv535518_ex5-1img001.jpg GRAPHIC 16555
8 GRAPHIC lg_novavax.jpg GRAPHIC 198771
  Complete submission text file 0001104659-19-077299.txt   1408270
Mailing Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-235761 | Film No.: 191319493
SIC: 2836 Biological Products, (No Diagnostic Substances)